The risk of premalignant and malignant pathology in endomentrial polyps: Should every polyp be resected?

Minerva Ginecologica

Volumn 59, Issue 2, 2007, Pages 117-124

  Papadia, A ^a   Gerbaldo, D ^a   Fulcheri, E ^b   Ragni, N ^a   Menoni, S ^b   Zanardi, S ^b   Brusaca B ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Endometrial cancer; Endometrial hyperplasia; Hysteroscopy; Polyps

Indexed keywords

HORMONE; TAMOXIFEN;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM POLYP; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTEROSCOPY; MAJOR CLINICAL STUDY; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; POLYPS; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34447520464     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Savelli L, De Iaco P, Santini D, Rosati F, Ghi T, Pignotti E et al. Histopathologic features and risk factors for benignity, hyperplasia and cancer in endometrial polyps. Am J Obstet Gynecol 2003;188:927-31.
2. Berlier M, Charles A, Galant C, Donnez J. Uterine side effects of tamoxifen: a need for systematic pretreatment screening. Obstet Gynecol 1998;91:40-4.
3. Perez-Medina T, Martinez O, Folgueira G, Bajo J. Which endometrial polyps should be resected? J Am Assoc Gynecol Laparosc 1999;6:71-4.
4. Epstein E, Ramirez A, Skoog L, Valentin L. Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal bleeding. Acta Obstet Gynecol Scand 2000;80:1131-6.
5. Schlaen I, Bergeron C, Ferenczy A. Endometrial polyps: a study of 204 cases. Surg Pathol 1988;1:375-82.
6. Goldstein SR, Monteagudo A, Popiolek D, Mayberry P, Timor-Tritsch I. Evaluation of endometrial polyps. Am J Obstet Gynecol 2002;186:669-74.
7. Caspi B, Appelman Z, Goldchmit R, Ashkenazi M, Haruvy Y, Hagay Z. The bright edge of the endometrial polyps. Pathology 1972;108:47-53.
8. rd Series Fascicle 3 American Registry of Pathology Washington, DC 1992.
9. Hileeto D, Fadare O, Martel M, Zheng W. Age dependent association of endometrial polyps with increased risk of cancer involvement. World J Surg Oncol 2005;3:7-14.
10. Ben-Arie A, Goldchmit C, Laviv Y, Levy R, Caspi B, Huszar M et al. The malignant potential of endometrial polyps. Eur J Obstet Gynecol Biol Reprod 2004;115:206-10.
11. Lev-Sagi A, Hamani Y, Imbar T, Hurwitz A, Lavy Y. The significance of intrauterine lesions detected by ultrasound in asymptomatic postmenopausal patients. BJOG 2005;112:379-81.
12. Shushan A, Revel A, Rojansky N. How often are endometrial polyps malignant? Gynecol Obstet Invest 2004;58:212-5.
13. Machtinger R, Korach J, Padoa A, Fridman E, Zolti M, Segal J et al. Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps: risk factors for premalignancy and malignancy. Int J Gynecol Cancer 2005;15:325-8.
14. Orvieto R, Bar-Hava I, Dicker D, Bar J, Ben-Rafael Z, Neri A. Endometrial polyps during menopause: characterization and significance. Acta Obstet Gynecol Scand 1999;78:883-6.
15. Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982;49:2547-59.
16. th edition. New York: Lippincott Williams and Wilkins; 824.p.824.
17. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994:86:527.
18. Rose PG. Endometrial carcinoma. N Engl J Med 1996;335:640-9.
19. Motashaw ND, Dave S. Complications of hysteroscopy. Gynecol Endosc 2001;10:203-10.
20. Bakour SH, Khan KS, Gupta JK. The risk of premalignant and malignant pathology in endometrial polyps. Acta Obstet Gynecol Scand 2000;79:317-20.
21. Ramondetta LM, Sherwood JB, Dunton CJ, Palazzo JP. Endometrial cancer in polyps associated with tamoxifen use. Am J Obstet Gynecol 1999;180:340-1.
22. Pettersson B, Adami HO, Lindgren A, Hesselius I. Endometrial polyps and hyperplasia as risk factors for endometrial carcinoma. A case-control study of curettage specimens. Acta Obstet Gynecol Scand 1985;64:653-9.
23. Gebauer G, Hafner A, Siebzehnrubl E, Lang N. Role of hysteroscopy in detection and extraction of endometrial polyps: results of a prospective study. Am J Obstet Gynecol 2001;184:59-63.
24. Brooks PG, Serden SP. Hysteroscopic findings after unsuccessful dilatation and curettage for abnormal uterine bleeding. Am J Obstet Gynecol 1988;158:1354-7.
25. Bonavolonta G, Rossetti A, Cannella PL, Campo S, Garcea N. [Curettage vs hysteroscopic resection]. Minerva Ginecol 1994;46:1-3.
26. Garuti G, Sambruni I, Colonnelli M, Luerti M. Accuracy of hysteroscopy in predicting histopathology of endometrium in 1500 women. J Am Assoc Gynecol Laparosc 2001;8:207-13.
27. de Wit A, Vleugles MPH, de Kruif JH. Diagnostic hysteroscopy: a valuable tool in the diagnosis of structural intra-cavital pathology and endometrial hyperplasia or carcinoma? Six years experience with non-clinical diagnostic hysteroscopy. Eur J Obstet Gynecol Reprod Biol 2003;110:79-82.
28. Alexopoulos ED, Simonis CD, Kidsley S. The value of outpatient office hysteroscopy in the management of post-menopausal bleeding: a review of 862 cases. Gynecol Endosc 200;9:107-12.
29. Colafranceschi M, Bettocchi S, Mencaglia L, van Herendael BJ. Missed hysteroscopic detection of uterine carcinoma before endometrial resection: report of three cases. Gynecol Oncol 1996;62:298-300.